insurance coverage for glp 1 medications of Obesity Therapies in State-Regulated Markets Why Won't Insurance Cover Weight

Salcedo I, et al

Adam Cifu explains that he frequently prescribes metformin

Patient uptake estimates that between 25 and 30 million Americans could be using GLP-1 therapies by 2030, up from approximately 10 million in 2026

The partnership with Novo Nordisk is a strong example of how GoodRx can leverage its extensive reach and scale of nearly 30 million consumers and over 1 million healthcare professionals annually to deliver meaningful savings on FDA-approved medications to people who might otherwise be priced out of therapy, Divya Iyer, senior vice president of go-to-market strategy at GoodRx told BioXconomy

In RA animal models, these drugs reduced joint damage and bone erosion, potentially preserving mobility and quality of life for patients

Clinical data shows that approximately 70% of weight lost returns within one year of discontinuing these medications, suggesting that sustained therapy may be necessary for durable results